Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.090
+0.010 (0.48%)
At close: Sep 26, 2025, 4:00 PM EDT
2.070
-0.020 (-0.96%)
After-hours: Sep 26, 2025, 6:45 PM EDT
Daré Bioscience Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Daré Bioscience stock ranges from a low of $8.00 to a high of $12. The average analyst price target of $10 forecasts a 378.47% increase in the stock price over the next year.
Price Target: $10.00 (+378.47%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +282.78% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +474.16% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +474.16% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +474.16% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +474.16% | Oct 24, 2024 |
Financial Forecast
Revenue This Year
681.36K
from 9.78K
Increased by 6,864.02%
Revenue Next Year
34.22M
from 681.36K
Increased by 4,922.46%
EPS This Year
-1.58
from -0.48
EPS Next Year
0.26
from -1.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.1M | 60.0M | |||
| Avg | 681,360 | 34.2M | |||
| Low | n/a | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21,363.6% | 8,699.3% | |||
| Avg | 6,864.0% | 4,922.5% | |||
| Low | - | 1,338.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.56 | 1.14 | |||
| Avg | -1.58 | 0.26 | |||
| Low | -1.58 | -0.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.